ImmunoGen, Inc. (NASDAQ:IMGN) Receives $25.77 Consensus Target Price from Analysts
Shares of ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report) have received an average recommendation of “Hold” from the twelve research firms that are covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price […]
More Stories
Trump Says Minnesota Officials Will Face ‘Day of Reckoning’ Amid Protests
By Jack Phillips President Donald Trump on Tuesday warned that state officials in Minnesota would face a “DAY OF RECKONING...
US Holiday Spending Jumped in December, Signaling Consumer Strength Into 2026
By Tom Ozimek American consumers closed out the holiday season with a strong December spending surge, adding to evidence that...
US Embassy Warns American Citizens Still in Iran to Leave ‘Now’
By Jack Phillips The U.S. State Department on Monday evening sent a warning to any Americans who are still remaining...
House Panel to Initiate Contempt Proceedings Against Bill Clinton, Comer Says
By Nathan Worcester WASHINGTON—House Oversight Committee Chairman James Comer (R-Ky.) said that his committee will move to hold President Bill...
Pentagon Injects $1 Billion Into L3Harris to Boost Missile Motor Output
By Tom Ozimek The U.S. government will invest $1 billion in L3Harris Technologies’ rocket motor business, a rare direct-to-supplier partnership...
Top Miro Alternatives in 2026 | Free Competitors of Miro for Startups
Looking for an alternative to Miro? Don’t worry, I’ll share a list of tools that are better than Miro. This...